Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardioprotective Effects of Empagliflozin in Breast Cancer Patients Receiving Chemotherapy: A Pilot Study

NCT07883512 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT07883512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07883512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardioprotective Effects of Empagliflozin in Breast Cancer Patients Receiving Chemotherapy: A Pilot Study
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
September 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, supportive care in cancer